Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$882k
1 round on record
Latest round
$882k
Venture round · Oct 2024 · 2 yr ago
Backers
1
Wavemaker Three-Sixty Health
The money's age
Due for its next round
24 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2024 | $882k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | SeqOnce BioSciences, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Christopher AngermayerExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Overview
Error 1000. You've requested a page on a website (seqonce.com) that is on the Cloudflare network. Unfortunately, it is resolving to an IP address that is creating a conflict within Cloudflare's system.
People

Christopher Angermayer
Executive Officer, Director

Joseph Dunham
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Carlsbad
United States
HQ
Financials
Total raised
$882k
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $882k | Details |
